Talk:Vimentin
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Further reading
[edit]This paper should be included here as a comprehensive overview of vimentin as a therapeutic target and as the only paper that describe a specific vimentin modulator ALD-R491 and its biological activity in multiple preclinical models
https://doi.org/10.1128/mBio.02542-21 Li et al. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases. Mbio, Journal of the Am Soc for Microbiology. Oct 2021 Dbsbd1260 (talk) 22:51, 28 November 2022 (UTC)